Retalux is a peptide vendor tracked in Finnrick's independent testing dataset. This page compiles batch-level results across 6 peptides and 27 tests, including ratings, observed price signals, recent test dates, and correction history where available.

Finnrick ratings are calculated from published sample data using the selected rating standard. The default standard evaluates purity, dose accuracy, and label quality, then adjusts low-volume results so small sample counts do not appear more certain than the data supports.

The most visible Retalux peptides in this dataset are 5-Amino-1MQ (3 tests), BPC-157 (3 tests) and MOTS-c (3 tests). Use the peptide table above to compare the current Finnrick rating, price per mg, and sample volume for each peptide.

Recent tests and corrections are shown below when available. Samples may be acquired by Finnrick directly or submitted through Finnrick testing programs; the goal is to make safety and supply-chain evidence easier to evaluate than vendor marketing claims alone. This page currently lists 27 recent tests. It also includes 2 corrections related to this vendor.

Corrections

2 corrections

2026-08-21

Finnrick data entry

Retatrutide (Retalux): stated amount corrected from 0.2 mg to 20.

2026-08-17

Finnrick data entry

The initial potency entered for sample y9tqqqp was 0.2 mg; however, the correct potency was 20 mg. The value has been reviewed and corrected to reflect the accurate potency.

Peptide testing

Ordered 5-Amino-1MQ from Retalux? Mail in a sample (US only) and let us test it.

Test my supply